Lithium (Li), Serum

 

Specimen requirement

Adult patient:

 

  Clotted blood tube (Serum gel separator clot activator tube)

 

Minimum blood volume: 5 mL

Paediatric patient:

Paediatric clotted blood tube

 

Number of vials: 1

 

Minimum blood volume: 0.8 mL

Authorisation code required

No

24 Hr available service

No

 

For suspected lithium overdose cases, please call Duty Biochemist for 'Urgent' lithium level testing.

Precaution

For monitoring of lithium therapy, blood should be drawn 8 - 12 hours after the last dose.

Method

Spectrophotometry

Reference interval

 

Therapeutic:  0.6 - 1.2 mmol/L
Toxicity reported:  > 2.0 mmol/L 

 

(Source: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 4th ed. 2005)

Clinical indication

Therapeutic drug monitoring

Result interpretation

Lithium half-life is 8 - 20 hours; may be prolonged in renal failure.

 

When levels are > 1.5 mmol/L, lithium therapy should be discontinued and the patient assessed for toxic symptoms. Symptoms of lithium intoxication include: sluggishness, drowsiness, muscle weakness, and ataxia.

 

Lithium level > 1.2 mmol/L may be toxic in older patients.

 

Increased levels may occur in sodium depletion, e.g. associated with diuretics.

Measurement of uncertainty

See table.

Frequency of measurement

Daily